Shanghai Zhongshan Hospital

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

319

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

12 drugs in development

Phase 32

Phase 28

Phase 11

Preclinical4

By Therapeutic Area

top 4

Oncology

853%

Cardiovascular

17%

Dermatology

17%

Infectious Disease

17%

R&D Momentum

94/100

Pipeline Velocity

79/100

Trial Completion Rate

89/100

Pipeline Concentration

37/100

Pipeline Freshness

59/100

Strategic Signals

↗Active in Cardiovascular but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Nov 4, 2026

Completed

A Decision-Context-Aligned Multicohort Framework for PF-Organized Corticosteroid-Associated Heterogeneity in Sepsis

Oct 27, 2026

Completed

The Efficacy and Safety of Tofacitinib in Patients With Glucocorticoid Resistant ICIs-related Myocarditis: a Single-arm, Prospective, Phase 2 Trial

Oct 23, 2026

Recruiting

Achieving Sustained Weight Control Via Exercise, Nutrition & Drugs (Mazdutide) (ASCEND- 1 Trial)

Earlier

Oct 17, 2026TrialEfficacy and Safety of Glofitamab, Polatuzumab Vedotin and Zanubrutinib in the First-line Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma (DLBCL): A Single-center, Single-arm, Prospective, Phase II Trial

Oct 14, 2026TrialFeasibility Study of a Multicomponent Sleep and Circadian Rhythm Intervention in Surgical Intensive Care Unit Patients

Oct 14, 2026TrialIncidence and Associated Factors of Abnormal Uterine Bleeding During Menstruation in Chinese Women of Childbearing Age Receiving Various Oral Antithrombotic Regimens After Cardiovascular Surgery: A Prospective Longitudinal Observational Study

Oct 10, 2026TrialClinical Phenotypes of ICU Delirium and Subsequent Impairment of Physical, Cognitive and Mental Health During Transition From ICU to Hospital Wards

Oct 9, 2026TrialA Prospective, Randomized, Controlled Mechanism Study of Thymosin Alpha-1 in Reshaping the "Immune Resilience" Trajectory of Immunosuppressed Sepsis Patients

1 more events

Oct 9, 2026TrialProteomic Analysis and Clinical Efficacy Evaluation of Hemoadsorption Therapy in Sepsis

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

IndobufenPreclinical

Showing 15 of 16 programs

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)

Shanghai Zhongshan Hospital

Pipeline Snapshot

Recent Activity

Company Info

Drug Pipeline

Cardiovascular

Dermatology

Oncology

Unknown / Other

Cardiovascular

Dermatology

Oncology

Unknown / Other